HZYMES has established itself as a trusted partner in the mRNA and saRNA drug development space, providing cutting-edge solutions for the pharmaceutical industry. With a comprehensive platform that covers sequence design, plasmid production, mRNA synthesis, purification, and LNP preparation, HZYMES is driving innovation in nucleic acid drugs, antibody drugs, protein replacement therapies, and cell & gene therapies.

Hzymes has advanced technology and extensive experience in the RNA field, offering raw enzymes, nucleotides, quality control kits, and cell/animal validation services.

After years of development, nucleic acid vaccines have reached a pivotal moment—mRNA vaccines provide even greater imaginative possibilities for this field. The topic of "The Current Status and Future of the Chinese Vaccine Market" has increasingly garnered attention and discussion within the industry.